Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

6.245 -0.025 (-0.40%)
Streaming Delayed Price Updated: 11:38 AM EDT, Sep 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
40 41 Next >
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in Upcoming Maxim Group Virtual Growth Conference
Via Investor Brand Network
Cybin to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30, 2022
From Cybin Inc.
Via Business Wire
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 10, 2022
GAINERS: Revive Therapeutics (OTC: 
Via Benzinga
Cybin Eyes Potential Of First-Of-Its-Kind Study
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cybin (NYSE American: CYBN) (NEO: CYBN... 
Via Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From March 9, 2022
GAINERS: ATAI Life Sciences (NASDAQ: 
Via Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ... 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From March 8, 2022
GAINERS: TripAdvisor (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 7, 2022
GAINERS: GH Research (NASDAQ: 
Via Benzinga
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
Via Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From March 4, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 3, 2022
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
Cybin Teams With Chopra Foundation To Foster Psychedelics Awareness
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Teams with Chopra Foundation to Foster Psychedelics Awareness
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From March 2, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Teams Up with Chopra Foundation to Foster Psychedelics Therapy Awareness
Via Investor Brand Network
Psychedelic Therapies Offer Hope For Mental Health
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate in Fireside Chat at Oppenheimer Annual Healthcare Conference
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From March 1, 2022
GAINERS: Cybin (AMEX: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Cybin's Study To Potentially Open New Frontiers In Psychedelics
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
Cybin’s (NYSE American: CYBN) (NEO: CYBN) Study to Potentially Open New Frontiers in Psychedelics
Via Investor Brand Network
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.